Novo Nordisk
Empresa farmacéutica global con sede en Dinamarca que desarrolla medicamentos para la diabetes, la obesidad y otras enfermedades crónicas.
Regístrate para leer casos de estudio completos, acceder a métricas detalladas y recibir todos los reportes.
Casos de uso (2)
Novo Nordisk is a century-old pharmaceutical leader focused on defeating chronic diseases like diabetes and obesity, with development teams spanning dozens of countries and billions of clinical trial data points. The company deployed the Databricks Data Intelligence Platform to unify siloed clinical data into a governed lakehouse, enabling AI-driven insights, cross-team collaboration, and natural-language data exploration across its research organization. In 9 months it moved from concept to production MVP, and today over 20% of its development organization actively uses clinical data—with $157M in projected net new value and $14M in efficiency gains from optimized clinical trials.
Novo Nordisk built NovoScribe using Claude Code to automate clinical study report generation, cutting documentation time from 10+ weeks to 10 minutes.